According to a report in the Winston-Salem Journal, sales prospects for Juul electronic cigarettes are not looking good, which could benefit Vuse in expanding its market and increasing its market share.
Image source: BAT (referring to Baidu, Alibaba, and Tencent)
According to the latest analysis of convenience store data by Nielsen, Vuse's market share increased from 37.4% to 39% in the four weeks ending August 13, while Juul's market share decreased from 30.7% to 29.4%. Meanwhile, third-ranked Njoy's market share dropped from 3% to 2.9%, and Fontem Ventures' blu e-cigarette slid from 1.7% to 1.6%.
In June, the US Food and Drug Administration (FDA) rejected Juul's premarket tobacco product application (PMTA) and issued a marketing denial order. The FDA stated that the evidence submitted by the company was insufficient to prove that its products were appropriate for protecting public health.
Although the FDA subsequently lifted its marketing refusal order, citing the need for further scientific examination of the application, it emphasized that the suspension does not mean a revocation of the MDO, putting Juul in a difficult situation.
In contrast, Vuse has received marketing approval from the FDA for multiple products, including Vuse Vibe, Vuse Ciro, and Vuse Solo.
Goldman Sachs analyst Bonnie Herzog stated in an investor note that Juul's decline in market share occurred partly after the FDA issued a marketing denial order for Juul, causing confusion.
In May 2019, before facing regulatory pressure, Juul held a dominating market share of 74.6% in the United States electronic cigarette market with its flavored products.
Translation: Statement
This article is compiled from third-party information and is only intended for communication and learning within the industry.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness and accuracy of the article's content. The translation of this article is solely intended for industry exchange and research purposes.
Due to limitations in translation ability, the compiled article may differ in expression from the original text. Please refer to the original text for accuracy.
In regards to any domestic, Hong Kong, Taiwan or foreign related statements and positions, 2FIRSTS fully aligns with the Chinese government.
The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
